Preparation and Evaluation of Liposomal Clarithromycin with Antimicrobial Effect

Wenxi Zhang,Guanghua Peng,Maoyuan Song,Jiaxing Wang,Mengya Yin,Jiajia Li,Yajie Liu,Yuanyuan Zhang,Xinru Li
DOI: https://doi.org/10.5246/jcps.2018.06.041
2018-01-01
Journal of Chinese Pharmaceutical Sciences
Abstract:In this study, we developed a novel liposomal delivery system modified by Tat peptide and wheat germ agglutinin (WGA) with antimicrobial effect. Physicochemical parameters, in vitro antimicrobial, time-kill study, cellular uptake, biofilm formation inhibition and in vivo antibacterial efficacy against Methicillin-resistant Staphylococcus aureus (MRSA) were investigated. Minimum inhibitory concentrations (MICs) and colony-forming units (CFUs) in the time-kill study for Tat-WGA-modified liposomal clarithromycin (CLA-Tat WGALip) were lower than those of free and other modified liposomal CLA. Flow cytometry analysis disclosed that Tat WGALip delivered more coumarin 6 into bacteria. Furthermore, Tat-WGA-modified liposomal CLA efficiently inhibited the formation of MRSA biofiom. CFU of MRSA in the abscess of mice treated with CLA-Tat WGALip was significantly lower than that of any others (P<0.01). Collectively, liposomal delivery system modified by Tat and WGA could be a promising anti-resistant infection strategy.
What problem does this paper attempt to address?